PET-MRI Imaging in Patients With Acute Neurovascular Syndrome

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-10-12

Study Completion Date

2020-01-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Ischaemic stroke is a major cause of death and disability worldwide. In patients with recent stroke, the 18F-fluoride positron emission tomography-computed tomography highlights high-risk culprit carotid plaque and is more discriminatory than 18F-fluorodeoxyglucose. Using hybrid positron emission tomography-magnetic resonance imaging investigators propose to build upon these findings by prospectively assessing 18F-fluoride uptake in a broad range of patients with acute transient ischaemic attack or ischaemic stroke. Investigators will specifically examine the association of 18F-fluoride uptake with multiparametric magnetic resonance imaging assessments of atherosclerotic plaque, especially the role of thrombus and lipid. Finally, using transcranial Doppler and diffusion-weighted magnetic resonance brain imaging, an assessment of the functional consequences of 18F-fluoride-positive atherosclerotic plaque will be performed. If successful, this technique has a number of valuable translational applications including the better selection of patients for carotid intervention.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

PET-MRI Imaging in Patients With Symptomatic Carotid Artery Stenosis

NCT03215550

Stroke Carotid Stenosis

COMPLETED

Proving Utility of a New Field-cycling MRI Prototype in Acute Stroke Patients

NCT07004140

Stroke Acute

RECRUITING

Imaging of Unstable Carotid Plaque in Patient Referred to Endarterectomy

NCT03353103

Carotid Artery Stenosis

UNKNOWN PHASE2

Magnetic Resonance Post-contrast Vascular Hyperintensities at 3 T: a Sensitive Sign of Vascular Occlusion in Acute Ischaemic Stroke

NCT03971526

Acute Ischaemic Stroke

COMPLETED

ProSPective Evaluation of Non-contrast sINe spiN Flat-dEtectoR CT for the Detection of Intracranial hemorrhageS

NCT05458908

Stroke

ACTIVE_NOT_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The ability to identify the culprit carotid plaque represents a key goal in carotid artery imaging. Although an array of non-invasive imaging techniques can detect a wide spectrum of complementary high-risk characteristics, no single modality can reliably identify vulnerable plaques associated with future stroke development. Substantial histological data suggests that specific plaque components identify patients at high-risk for future ipsilateral stroke and cardiovascular events. This implies that investigators need to look beyond the traditional paradigm where the basis for carotid endarterectomy were formulated by an invasive imaging modality that provided no information on the arterial wall composition. Alternative imaging strategies are therefore required targeting not only in vivo carotid morphology but also plaque biology and disease activity. This is fundamental to optimal risk-stratification and appropriate selection of patients for high-risk vascular intervention. One new approach is to use non-invasive molecular imaging targeted at plaque biology using hybrid systems such as positron emission tomography-magnetic resonance imaging.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke Carotid Stenosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Carotid

Patients with carotid artery stenosis who either do not meet surgical criteria (\< 50% by NASCET criteria for men, \<70% for women), or meet criteria but do not undergo surgery (surgery declined or not offered) and are currently treated with OMT. This cohort will be recruited from the acute TIA clinics and Vascular Laboratory logbooks at Edinburgh Royal Infirmary and Western General Hospital.

18F PET-MRI

Intervention Type RADIATION

18F-fluoride Hybrid PET-MRI

Transcranial Doppler

Intervention Type DIAGNOSTIC_TEST

Microembolic Signals detection

Non Carotid

Patients with an atherosclerotic disease in the aortic arch including origins of its major branches other than the internal carotid artery treated with OMT. Patients with a cardiac source of embolism will be excluded from the study. This group will be recruited from the acute TIA clinics and inpatients at Edinburgh Royal Infirmary and Western General Hospital.

18F PET-MRI

Intervention Type RADIATION

18F-fluoride Hybrid PET-MRI

Transcranial Doppler

Intervention Type DIAGNOSTIC_TEST

Microembolic Signals detection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

18F PET-MRI

18F-fluoride Hybrid PET-MRI

Intervention Type RADIATION

Transcranial Doppler

Microembolic Signals detection

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients above 40 years of age with carotid artery stenosis that do not achieve criteria for CEA (\<50% for men, \<70% for women, by NASCET criteria) or the patient has declined CEA.
2. Patients above 40 years of age with atherosclerotic disease of aortic arch and its branches.

Exclusion Criteria

1. Patients with new stroke and a modified Rankin score \>3
2. Chronic kidney disease with an estimated Glomerular Filtration Rate (eGFR) of \<30 ml/min/1.73 m2
3. Atrial fibrillation
4. Pregnant women
5. Prior ipsilateral carotid intervention
6. Prior neck radiotherapy
7. Inability to tolerate the supine position
8. Participation in the study would result in delay to surgery
9. Psychiatric illness/social situations that would limit compliance with study requirements
10. History of allergic reaction attributed to 18F-Fluoride
11. History of allergic reaction to gadolinium contrast media
12. Metal implants or devices including pacemakers and defibrillators

Minimum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No